Back
ESC Professional Premium Access

The association between dyslipidaemia treatment and the risk of clinical events in edoxaban-treated patients with atrial fibrillation: insights from the 2-year follow-up of ETNA-AF-Europe

Session: Stroke prevention in atrial fibrillation
Topic: Oral Anticoagulation
Speaker: Doctor T. de Vries (Amsterdam, NL)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Tim Anthonie Christiaan de Vries

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))
0 follower

6 more presentations in this session

Associations of soluble fms-like tyrosine kinase-1 with cardiovascular events and stroke in patients with atrial fibrillation and suspected or known coronary artery disease: The EXCEED-J Study

Speaker: Doctor K. Hasegawa (Kyoto, JP)

Access
Abstract
Slides
Like
Thumbnail

Prediction of atrial fibrillation in patients with embolic stroke with undetermined source using electrocardiogram deep learning algorithm and clinical risk factors

Speaker: Associate Professor J. Lee (Seongnam, KR)

Access
Abstract
Slides
Like
Thumbnail

We all know A and B, but what about C? Exploring the management of modifiable risk factors in patients with atrial fibrillation.

Speaker: Miss D. Verhaert (Nijmegen, NL)

Access
Abstract
Slides
Like
Thumbnail

Incidence and risk factors for major bleeding events in atrial fibrillation patients on direct oral anticoagulant therapy: data from the National Patient-Centered Clinical Research Network

Speaker: Doctor K. Arps (Durham, US)

Access
Abstract
Slides
Like
Thumbnail

Should we initiate oral anticoagulants for patients with atrial fibrillation staying well without oral anticoagulants for years?

Speaker: Doctor T. Chao (Taipei, TW)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Stroke prevention in atrial fibrillation

Speakers: Doctor T. de Vries, Doctor K. Hasegawa, Associate Professor J. Lee, Miss D. Verhaert, Doctor K. Arps...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources